

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 5.86162463 |
| 2 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 5.70403392 |
| 3 | negative regulation of phagocytosis (GO:0050765) | 5.66677338 |
| 4 | antigen processing and presentation of endogenous antigen (GO:0019883) | 5.22080734 |
| 5 | regulation of B cell receptor signaling pathway (GO:0050855) | 5.21055027 |
| 6 | antigen processing and presentation via MHC class Ib (GO:0002475) | 4.92343359 |
| 7 | regulation of mast cell degranulation (GO:0043304) | 4.66284262 |
| 8 | positive regulation of gamma-delta T cell activation (GO:0046645) | 4.48757120 |
| 9 | regulation of antigen processing and presentation of peptide antigen (GO:0002583) | 4.46086598 |
| 10 | regulation of mast cell activation involved in immune response (GO:0033006) | 4.27542643 |
| 11 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 4.23619726 |
| 12 | negative regulation of cell killing (GO:0031342) | 4.23619726 |
| 13 | regulation of activation of Janus kinase activity (GO:0010533) | 4.10203105 |
| 14 | regulation of leukocyte degranulation (GO:0043300) | 4.08722942 |
| 15 | negative regulation of erythrocyte differentiation (GO:0045647) | 3.92662177 |
| 16 | regulation of myeloid leukocyte mediated immunity (GO:0002886) | 3.86612964 |
| 17 | B cell receptor signaling pathway (GO:0050853) | 3.64552612 |
| 18 | germinal center formation (GO:0002467) | 3.60188783 |
| 19 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 3.59900432 |
| 20 | negative regulation of mast cell activation (GO:0033004) | 3.58371206 |
| 21 | detection of bacterium (GO:0016045) | 3.56553658 |
| 22 | regulation of gamma-delta T cell activation (GO:0046643) | 3.49395902 |
| 23 | detection of other organism (GO:0098543) | 3.43293800 |
| 24 | keratinization (GO:0031424) | 3.42539145 |
| 25 | establishment of skin barrier (GO:0061436) | 3.38970464 |
| 26 | negative regulation of alpha-beta T cell activation (GO:0046636) | 3.34471051 |
| 27 | negative regulation of leukocyte mediated immunity (GO:0002704) | 3.31939153 |
| 28 | desmosome organization (GO:0002934) | 3.31807292 |
| 29 | regulation of water loss via skin (GO:0033561) | 3.30925469 |
| 30 | regulation of mast cell activation (GO:0033003) | 3.28940161 |
| 31 | positive thymic T cell selection (GO:0045059) | 3.26406535 |
| 32 | negative regulation of B cell proliferation (GO:0030889) | 3.24213500 |
| 33 | regulation of regulated secretory pathway (GO:1903305) | 3.19602423 |
| 34 | thymic T cell selection (GO:0045061) | 3.17275849 |
| 35 | response to laminar fluid shear stress (GO:0034616) | 3.14964459 |
| 36 | regulation of gamma-delta T cell differentiation (GO:0045586) | 3.14038114 |
| 37 | response to muramyl dipeptide (GO:0032495) | 3.06929903 |
| 38 | negative regulation of amyloid precursor protein catabolic process (GO:1902992) | 3.03489554 |
| 39 | negative regulation of lipopolysaccharide-mediated signaling pathway (GO:0031665) | 3.00171951 |
| 40 | mannose metabolic process (GO:0006013) | 2.96172841 |
| 41 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 2.95549400 |
| 42 | modulation by symbiont of host immune response (GO:0052553) | 2.95549400 |
| 43 | positive regulation by symbiont of host defense response (GO:0052509) | 2.95549400 |
| 44 | modulation by symbiont of host defense response (GO:0052031) | 2.95549400 |
| 45 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 2.95549400 |
| 46 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 2.95549400 |
| 47 | tolerance induction (GO:0002507) | 2.92417174 |
| 48 | positive regulation of Rap GTPase activity (GO:0032854) | 2.91094265 |
| 49 | modulation by symbiont of host cellular process (GO:0044068) | 2.86153480 |
| 50 | macrophage activation involved in immune response (GO:0002281) | 2.86101701 |
| 51 | detection of external biotic stimulus (GO:0098581) | 2.79494280 |
| 52 | positive regulation of keratinocyte differentiation (GO:0045618) | 2.78014212 |
| 53 | histone H3 deacetylation (GO:0070932) | 2.77887060 |
| 54 | negative thymic T cell selection (GO:0045060) | 2.77462278 |
| 55 | negative regulation of myotube differentiation (GO:0010832) | 2.76942920 |
| 56 | T cell selection (GO:0045058) | 2.74776450 |
| 57 | response to peptidoglycan (GO:0032494) | 2.74192470 |
| 58 | B cell homeostasis (GO:0001782) | 2.69854607 |
| 59 | positive regulation of antigen processing and presentation (GO:0002579) | 2.68578148 |
| 60 | positive regulation of type I interferon-mediated signaling pathway (GO:0060340) | 2.68498214 |
| 61 | leukocyte aggregation (GO:0070486) | 2.68367917 |
| 62 | neutrophil activation involved in immune response (GO:0002283) | 2.68056641 |
| 63 | regulation of antigen processing and presentation (GO:0002577) | 2.67255978 |
| 64 | Rap protein signal transduction (GO:0032486) | 2.65357474 |
| 65 | activation of Rac GTPase activity (GO:0032863) | 2.65204231 |
| 66 | negative regulation of T cell mediated immunity (GO:0002710) | 2.64560530 |
| 67 | histone H4 deacetylation (GO:0070933) | 2.64511122 |
| 68 | histone H3-K36 demethylation (GO:0070544) | 2.59833474 |
| 69 | negative regulation of antigen receptor-mediated signaling pathway (GO:0050858) | 2.58366119 |
| 70 | positive regulation of cellular amide metabolic process (GO:0034250) | 2.57522740 |
| 71 | negative regulation of toll-like receptor signaling pathway (GO:0034122) | 2.56116702 |
| 72 | negative T cell selection (GO:0043383) | 2.55234043 |
| 73 | positive regulation of CREB transcription factor activity (GO:0032793) | 2.55110597 |
| 74 | positive T cell selection (GO:0043368) | 2.52975233 |
| 75 | regulation of natural killer cell differentiation (GO:0032823) | 2.50894027 |
| 76 | positive regulation of mast cell activation (GO:0033005) | 2.50234195 |
| 77 | negative regulation of lymphocyte mediated immunity (GO:0002707) | 2.50147484 |
| 78 | regulation of histone H3-K27 methylation (GO:0061085) | 2.49561080 |
| 79 | CD4-positive or CD8-positive, alpha-beta T cell lineage commitment (GO:0043369) | 2.49185384 |
| 80 | positive regulation of natural killer cell differentiation (GO:0032825) | 2.47982375 |
| 81 | positive regulation of leukocyte degranulation (GO:0043302) | 2.46829666 |
| 82 | positive regulation of mast cell degranulation (GO:0043306) | 2.44734534 |
| 83 | positive regulation of mast cell activation involved in immune response (GO:0033008) | 2.44734534 |
| 84 | granulocyte activation (GO:0036230) | 2.43181274 |
| 85 | regulation of antigen receptor-mediated signaling pathway (GO:0050854) | 2.41860511 |
| 86 | negative regulation of viral release from host cell (GO:1902187) | 2.41706556 |
| 87 | modulation by virus of host process (GO:0019054) | 2.41124906 |
| 88 | activation of JUN kinase activity (GO:0007257) | 2.40803266 |
| 89 | myeloid cell activation involved in immune response (GO:0002275) | 2.40102506 |
| 90 | immunoglobulin mediated immune response (GO:0016064) | 2.40003412 |
| 91 | regulation of cellular amide metabolic process (GO:0034248) | 2.38484510 |
| 92 | negative regulation of toll-like receptor 4 signaling pathway (GO:0034144) | 2.38298929 |
| 93 | detection of biotic stimulus (GO:0009595) | 2.36210816 |
| 94 | positive regulation of B cell differentiation (GO:0045579) | 2.34366481 |
| 95 | T cell homeostasis (GO:0043029) | 2.34136782 |
| 96 | peptide cross-linking (GO:0018149) | 2.33185924 |
| 97 | regulation of tumor necrosis factor biosynthetic process (GO:0042534) | 2.32929156 |
| 98 | regulation of T cell receptor signaling pathway (GO:0050856) | 2.32584259 |
| 99 | regulation of type I interferon-mediated signaling pathway (GO:0060338) | 2.31989868 |
| 100 | positive regulation of phosphoprotein phosphatase activity (GO:0032516) | 2.31486874 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | * MYC_22102868_ChIP-Seq_BL_Human | 3.68120304 |
| 2 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 3.23862841 |
| 3 | VDR_21846776_ChIP-Seq_THP-1_Human | 3.21683818 |
| 4 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 2.86197595 |
| 5 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 2.78118214 |
| 6 | * KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 2.60556979 |
| 7 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 2.53499130 |
| 8 | GATA1_22025678_ChIP-Seq_K562_Human | 2.49618633 |
| 9 | TCF7_22412390_ChIP-Seq_EML_Mouse | 2.48330106 |
| 10 | LXR_22292898_ChIP-Seq_THP-1_Human | 2.35819127 |
| 11 | KDM2B_26808549_Chip-Seq_DND41_Human | 2.25258401 |
| 12 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 2.24157977 |
| 13 | MAF_26560356_Chip-Seq_TH1_Human | 2.20205717 |
| 14 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 2.10825755 |
| 15 | * E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 2.10154002 |
| 16 | VDR_24763502_ChIP-Seq_THP-1_Human | 2.09358491 |
| 17 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 2.08049877 |
| 18 | RACK7_27058665_Chip-Seq_MCF-7_Human | 2.05790673 |
| 19 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 2.04413455 |
| 20 | UTX_26944678_Chip-Seq_JUKART_Human | 1.96120947 |
| 21 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.95415630 |
| 22 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.95285382 |
| 23 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.95189060 |
| 24 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.93990781 |
| 25 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 1.91598021 |
| 26 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 1.91460332 |
| 27 | MAF_26560356_Chip-Seq_TH2_Human | 1.91347919 |
| 28 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.76068382 |
| 29 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 1.72086645 |
| 30 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.69075609 |
| 31 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.65537633 |
| 32 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.63437149 |
| 33 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.62845404 |
| 34 | P68_20966046_ChIP-Seq_HELA_Human | 1.61814995 |
| 35 | KDM2B_26808549_Chip-Seq_JURKAT_Human | 1.59093822 |
| 36 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.53111692 |
| 37 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.52821729 |
| 38 | MYB_26560356_Chip-Seq_TH1_Human | 1.52690328 |
| 39 | KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.52649996 |
| 40 | KDM2B_26808549_Chip-Seq_K562_Human | 1.52305154 |
| 41 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.51959456 |
| 42 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 1.50618802 |
| 43 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.50346430 |
| 44 | SMC4_20622854_ChIP-Seq_HELA_Human | 1.49606050 |
| 45 | BCOR_27268052_Chip-Seq_Bcells_Human | 1.47928910 |
| 46 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 1.46106168 |
| 47 | RUNX_20019798_ChIP-Seq_JUKART_Human | 1.45625209 |
| 48 | RUNX1_27514584_Chip-Seq_MCF-7_Human | 1.45355224 |
| 49 | * CTCF_27219007_Chip-Seq_ERYTHROID_Human | 1.44372778 |
| 50 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 1.42989935 |
| 51 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 1.40815888 |
| 52 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 1.39505946 |
| 53 | SA1_27219007_Chip-Seq_ERYTHROID_Human | 1.34882729 |
| 54 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.33300457 |
| 55 | SPI1_23127762_ChIP-Seq_K562_Human | 1.32437393 |
| 56 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.31097744 |
| 57 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.31070164 |
| 58 | MYB_26560356_Chip-Seq_TH2_Human | 1.30411384 |
| 59 | BCL6_27268052_Chip-Seq_Bcells_Human | 1.29482226 |
| 60 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.29163274 |
| 61 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 1.27831820 |
| 62 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 1.27302557 |
| 63 | CREB1_26743006_Chip-Seq_LNCaP_Human | 1.26691147 |
| 64 | CREB1_26743006_Chip-Seq_LNCaP-abl_Human | 1.26300613 |
| 65 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.25212697 |
| 66 | * P63_26484246_Chip-Seq_KERATINOCYTES_Human | 1.21432900 |
| 67 | ATF3_27146783_Chip-Seq_COLON_Human | 1.20785072 |
| 68 | GATA1_19941826_ChIP-Seq_K562_Human | 1.20169665 |
| 69 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 1.19918375 |
| 70 | NCOR1_26117541_ChIP-Seq_K562_Human | 1.17884339 |
| 71 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 1.17023444 |
| 72 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 1.16778206 |
| 73 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 1.15706601 |
| 74 | SPI1_23547873_ChIP-Seq_NB4_Human | 1.14344870 |
| 75 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.14211314 |
| 76 | EGR1_20690147_ChIP-Seq_ERYTHROLEUKEMIA_Human | 1.13708421 |
| 77 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.12776164 |
| 78 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.12727094 |
| 79 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.12699859 |
| 80 | SMAD3_18955504_ChIP-ChIP_HaCaT_Human | 1.12188575 |
| 81 | SMAD2_18955504_ChIP-ChIP_HaCaT_Human | 1.12188575 |
| 82 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 1.10365790 |
| 83 | P300_27058665_Chip-Seq_ZR-75-30cells_Human | 1.09672155 |
| 84 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.08770016 |
| 85 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 1.08579339 |
| 86 | SMAD2/3_21741376_ChIP-Seq_ESCs_Human | 1.07036866 |
| 87 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.06920752 |
| 88 | TP53_22127205_ChIP-Seq_IMR90_Human | 1.06080362 |
| 89 | UBF1/2_26484160_Chip-Seq_HMEC-DERIVED_Human | 1.05682620 |
| 90 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.03591901 |
| 91 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 1.03062719 |
| 92 | DACH1_20351289_ChIP-Seq_MDA-MB-231_Human | 1.00776745 |
| 93 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 1.00654800 |
| 94 | RARB_24833708_ChIP-Seq_LIVER_Mouse | 0.99754823 |
| 95 | CIITA_25753668_ChIP-Seq_RAJI_Human | 0.99664310 |
| 96 | CTNNB1_20615089_ChIP-ChIP_FETAL_BRAIN_Human | 0.99593563 |
| 97 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.99385731 |
| 98 | E2F1_20622854_ChIP-Seq_HELA_Human | 0.99070747 |
| 99 | RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 0.98646434 |
| 100 | ELF3_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.98144641 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0003436_decreased_susceptibility_to | 2.98900462 |
| 2 | MP0002796_impaired_skin_barrier | 2.98747473 |
| 3 | MP0003763_abnormal_thymus_physiology | 2.97094336 |
| 4 | MP0010234_abnormal_vibrissa_follicle | 2.88186661 |
| 5 | MP0003705_abnormal_hypodermis_morpholog | 2.63374926 |
| 6 | MP0003303_peritoneal_inflammation | 2.58303624 |
| 7 | MP0001348_abnormal_lacrimal_gland | 2.41502678 |
| 8 | MP0001835_abnormal_antigen_presentation | 2.38115832 |
| 9 | MP0009840_abnormal_foam_cell | 2.34024128 |
| 10 | MP0004947_skin_inflammation | 2.23671013 |
| 11 | MP0004381_abnormal_hair_follicle | 2.23579937 |
| 12 | MP0001800_abnormal_humoral_immune | 2.16541992 |
| 13 | MP0000685_abnormal_immune_system | 2.15463487 |
| 14 | MP0002166_altered_tumor_susceptibility | 2.13083337 |
| 15 | MP0003300_gastrointestinal_ulcer | 2.11655667 |
| 16 | MP0005076_abnormal_cell_differentiation | 2.10111210 |
| 17 | MP0005000_abnormal_immune_tolerance | 2.05784133 |
| 18 | MP0003453_abnormal_keratinocyte_physiol | 2.02596066 |
| 19 | MP0001849_ear_inflammation | 1.95726028 |
| 20 | MP0004185_abnormal_adipocyte_glucose | 1.90212632 |
| 21 | MP0003191_abnormal_cellular_cholesterol | 1.88327113 |
| 22 | MP0005501_abnormal_skin_physiology | 1.86586354 |
| 23 | MP0002452_abnormal_antigen_presenting | 1.83207325 |
| 24 | MP0003646_muscle_fatigue | 1.82883843 |
| 25 | MP0001790_abnormal_immune_system | 1.82822139 |
| 26 | MP0005387_immune_system_phenotype | 1.82822139 |
| 27 | MP0002419_abnormal_innate_immunity | 1.79098488 |
| 28 | MP0005025_abnormal_response_to | 1.76762059 |
| 29 | MP0002723_abnormal_immune_serum | 1.75334331 |
| 30 | MP0009333_abnormal_splenocyte_physiolog | 1.75144719 |
| 31 | MP0002420_abnormal_adaptive_immunity | 1.74922841 |
| 32 | MP0001819_abnormal_immune_cell | 1.71236312 |
| 33 | MP0005451_abnormal_body_composition | 1.60770733 |
| 34 | MP0003566_abnormal_cell_adhesion | 1.60292594 |
| 35 | MP0002398_abnormal_bone_marrow | 1.58124513 |
| 36 | MP0002009_preneoplasia | 1.55787635 |
| 37 | MP0005671_abnormal_response_to | 1.54241912 |
| 38 | MP0003091_abnormal_cell_migration | 1.52682813 |
| 39 | MP0008057_abnormal_DNA_replication | 1.52645065 |
| 40 | MP0003183_abnormal_peptide_metabolism | 1.43996629 |
| 41 | MP0003172_abnormal_lysosome_physiology | 1.42330682 |
| 42 | MP0010155_abnormal_intestine_physiology | 1.42212668 |
| 43 | MP0002006_tumorigenesis | 1.41047767 |
| 44 | MP0000858_altered_metastatic_potential | 1.40682087 |
| 45 | MP0010307_abnormal_tumor_latency | 1.38717516 |
| 46 | MP0001216_abnormal_epidermal_layer | 1.38268161 |
| 47 | MP0009785_altered_susceptibility_to | 1.37961118 |
| 48 | MP0001873_stomach_inflammation | 1.36289950 |
| 49 | MP0000716_abnormal_immune_system | 1.36096822 |
| 50 | MP0005409_darkened_coat_color | 1.30194956 |
| 51 | MP0003828_pulmonary_edema | 1.29848442 |
| 52 | MP0005310_abnormal_salivary_gland | 1.29549729 |
| 53 | MP0001851_eye_inflammation | 1.27697086 |
| 54 | MP0002405_respiratory_system_inflammati | 1.27359938 |
| 55 | MP0004264_abnormal_extraembryonic_tissu | 1.26360987 |
| 56 | MP0002429_abnormal_blood_cell | 1.23147164 |
| 57 | MP0000015_abnormal_ear_pigmentation | 1.22047113 |
| 58 | MP0000703_abnormal_thymus_morphology | 1.17715829 |
| 59 | MP0009931_abnormal_skin_appearance | 1.16928269 |
| 60 | MP0005666_abnormal_adipose_tissue | 1.15917651 |
| 61 | MP0001853_heart_inflammation | 1.14891617 |
| 62 | MP0003724_increased_susceptibility_to | 1.14597827 |
| 63 | MP0002722_abnormal_immune_system | 1.14242761 |
| 64 | MP0005275_abnormal_skin_tensile | 1.11813743 |
| 65 | MP0000579_abnormal_nail_morphology | 1.09497758 |
| 66 | MP0001533_abnormal_skeleton_physiology | 1.08231029 |
| 67 | MP0002132_abnormal_respiratory_system | 1.08024598 |
| 68 | MP0000689_abnormal_spleen_morphology | 1.07849972 |
| 69 | MP0004808_abnormal_hematopoietic_stem | 1.07617124 |
| 70 | MP0002396_abnormal_hematopoietic_system | 1.06745921 |
| 71 | MP0005058_abnormal_lysosome_morphology | 1.06269279 |
| 72 | MP0005464_abnormal_platelet_physiology | 1.05577182 |
| 73 | MP0009278_abnormal_bone_marrow | 1.04842081 |
| 74 | MP0002998_abnormal_bone_remodeling | 1.04270830 |
| 75 | MP0002148_abnormal_hypersensitivity_rea | 1.03884929 |
| 76 | MP0001845_abnormal_inflammatory_respons | 1.02065119 |
| 77 | MP0000678_abnormal_parathyroid_gland | 1.01614209 |
| 78 | MP0002254_reproductive_system_inflammat | 0.99640850 |
| 79 | MP0005023_abnormal_wound_healing | 0.99590372 |
| 80 | MP0000490_abnormal_crypts_of | 0.98406197 |
| 81 | MP0004130_abnormal_muscle_cell | 0.90442747 |
| 82 | MP0003943_abnormal_hepatobiliary_system | 0.89824163 |
| 83 | MP0002933_joint_inflammation | 0.87481704 |
| 84 | MP0002060_abnormal_skin_morphology | 0.87065666 |
| 85 | MP0000377_abnormal_hair_follicle | 0.85844781 |
| 86 | MP0010352_gastrointestinal_tract_polyps | 0.85762544 |
| 87 | MP0003448_altered_tumor_morphology | 0.83860729 |
| 88 | MP0003656_abnormal_erythrocyte_physiolo | 0.83851697 |
| 89 | MP0002019_abnormal_tumor_incidence | 0.82739427 |
| 90 | MP0005375_adipose_tissue_phenotype | 0.82149930 |
| 91 | MP0003221_abnormal_cardiomyocyte_apopto | 0.80152741 |
| 92 | MP0008260_abnormal_autophagy | 0.80032432 |
| 93 | MP0003045_fibrosis | 0.79787312 |
| 94 | MP0002098_abnormal_vibrissa_morphology | 0.77513186 |
| 95 | MP0000367_abnormal_coat/_hair | 0.76980349 |
| 96 | MP0003866_abnormal_defecation | 0.75669490 |
| 97 | MP0008961_abnormal_basal_metabolism | 0.74781096 |
| 98 | MP0008469_abnormal_protein_level | 0.74400891 |
| 99 | MP0000467_abnormal_esophagus_morphology | 0.74308616 |
| 100 | MP0005397_hematopoietic_system_phenotyp | 0.73917998 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Increased IgE level (HP:0003212) | 4.60090512 |
| 2 | Eczematoid dermatitis (HP:0000976) | 4.19338673 |
| 3 | Birth length less than 3rd percentile (HP:0003561) | 3.53751143 |
| 4 | Abnormality of the fingertips (HP:0001211) | 3.47200873 |
| 5 | Hyperacusis (HP:0010780) | 3.44945411 |
| 6 | Breast hypoplasia (HP:0003187) | 3.38729067 |
| 7 | Broad face (HP:0000283) | 3.16958670 |
| 8 | Abnormality of nail color (HP:0100643) | 3.06866613 |
| 9 | Pustule (HP:0200039) | 3.00046332 |
| 10 | Thin bony cortex (HP:0002753) | 2.99094968 |
| 11 | Malnutrition (HP:0004395) | 2.91317633 |
| 12 | Lip pit (HP:0100267) | 2.90531343 |
| 13 | Recurrent bacterial skin infections (HP:0005406) | 2.76485546 |
| 14 | Testicular atrophy (HP:0000029) | 2.72940421 |
| 15 | Hemorrhage of the eye (HP:0011885) | 2.65704445 |
| 16 | Cellulitis (HP:0100658) | 2.59567094 |
| 17 | Increased connective tissue (HP:0009025) | 2.53451566 |
| 18 | Gastrointestinal infarctions (HP:0005244) | 2.42556751 |
| 19 | Palmoplantar hyperkeratosis (HP:0000972) | 2.35642588 |
| 20 | Renovascular hypertension (HP:0100817) | 2.35622359 |
| 21 | Abnormality of macrophages (HP:0004311) | 2.34889091 |
| 22 | Recurrent abscess formation (HP:0002722) | 2.34027439 |
| 23 | Recurrent viral infections (HP:0004429) | 2.33901194 |
| 24 | Mediastinal lymphadenopathy (HP:0100721) | 2.33157773 |
| 25 | Parkinsonism with favorable response to dopaminergic medication (HP:0002548) | 2.30459697 |
| 26 | Gingivitis (HP:0000230) | 2.26786461 |
| 27 | Meningitis (HP:0001287) | 2.26071709 |
| 28 | Obstructive sleep apnea (HP:0002870) | 2.24524800 |
| 29 | Plantar hyperkeratosis (HP:0007556) | 2.21956776 |
| 30 | Progressive external ophthalmoplegia (HP:0000590) | 2.20998377 |
| 31 | Colitis (HP:0002583) | 2.19578073 |
| 32 | Ragged-red muscle fibers (HP:0003200) | 2.14676526 |
| 33 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 2.13837014 |
| 34 | Recurrent pneumonia (HP:0006532) | 2.12677040 |
| 35 | Alopecia of scalp (HP:0002293) | 2.11846315 |
| 36 | Elevated erythrocyte sedimentation rate (HP:0003565) | 2.10559627 |
| 37 | Gastrointestinal inflammation (HP:0004386) | 2.10148222 |
| 38 | Emphysema (HP:0002097) | 2.08955972 |
| 39 | Palmar hyperkeratosis (HP:0010765) | 2.07822770 |
| 40 | Dysmetric saccades (HP:0000641) | 2.06596409 |
| 41 | Thick nail (HP:0001805) | 2.05831461 |
| 42 | Slow saccadic eye movements (HP:0000514) | 2.05797328 |
| 43 | Inflammation of the large intestine (HP:0002037) | 2.02429698 |
| 44 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 2.02162090 |
| 45 | Gastrointestinal stroma tumor (HP:0100723) | 2.02066677 |
| 46 | Chronic mucocutaneous candidiasis (HP:0002728) | 2.01875426 |
| 47 | Recurrent cutaneous fungal infections (HP:0011370) | 2.01875426 |
| 48 | Papilloma (HP:0012740) | 2.01556569 |
| 49 | Verrucae (HP:0200043) | 2.01556569 |
| 50 | Recurrent skin infections (HP:0001581) | 2.00429629 |
| 51 | Recurrent fungal infections (HP:0002841) | 2.00105096 |
| 52 | Spontaneous hematomas (HP:0007420) | 1.99211593 |
| 53 | Obstructive lung disease (HP:0006536) | 1.95403374 |
| 54 | Chronic obstructive pulmonary disease (HP:0006510) | 1.95403374 |
| 55 | Milia (HP:0001056) | 1.95354719 |
| 56 | Microretrognathia (HP:0000308) | 1.94590453 |
| 57 | Myositis (HP:0100614) | 1.92091559 |
| 58 | Agammaglobulinemia (HP:0004432) | 1.92049291 |
| 59 | Spondylolisthesis (HP:0003302) | 1.91417912 |
| 60 | Erythema (HP:0010783) | 1.90762208 |
| 61 | Easy fatigability (HP:0003388) | 1.88534281 |
| 62 | Abnormality of liposaccharide metabolism (HP:0010968) | 1.86627011 |
| 63 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 1.86627011 |
| 64 | Abnormality of glycolipid metabolism (HP:0010969) | 1.86627011 |
| 65 | Hypotrichosis (HP:0001006) | 1.85576452 |
| 66 | Depressed nasal tip (HP:0000437) | 1.85567794 |
| 67 | Axonal loss (HP:0003447) | 1.84927310 |
| 68 | Distal lower limb amyotrophy (HP:0008944) | 1.84302426 |
| 69 | Vasculitis (HP:0002633) | 1.83238466 |
| 70 | Disproportionate tall stature (HP:0001519) | 1.82986887 |
| 71 | Recurrent lower respiratory tract infections (HP:0002783) | 1.82443997 |
| 72 | Hypertriglyceridemia (HP:0002155) | 1.81947165 |
| 73 | Elfin facies (HP:0004428) | 1.79035998 |
| 74 | Insomnia (HP:0100785) | 1.78999168 |
| 75 | Nail dystrophy (HP:0008404) | 1.78547515 |
| 76 | Osteomyelitis (HP:0002754) | 1.77614809 |
| 77 | Orchitis (HP:0100796) | 1.76772621 |
| 78 | Cerebral inclusion bodies (HP:0100314) | 1.76378827 |
| 79 | Increased variability in muscle fiber diameter (HP:0003557) | 1.74775692 |
| 80 | Dyschromatopsia (HP:0007641) | 1.74513096 |
| 81 | Recurrent gram-negative bacterial infections (HP:0005420) | 1.73988061 |
| 82 | Skin ulcer (HP:0200042) | 1.70425154 |
| 83 | Urticaria (HP:0001025) | 1.69557508 |
| 84 | Flat acetabular roof (HP:0003180) | 1.69533216 |
| 85 | Ulnar bowing (HP:0003031) | 1.67694805 |
| 86 | Ankyloglossia (HP:0010296) | 1.65744839 |
| 87 | Retrobulbar optic neuritis (HP:0100654) | 1.65148183 |
| 88 | Optic neuritis (HP:0100653) | 1.65148183 |
| 89 | Joint hemorrhage (HP:0005261) | 1.64507342 |
| 90 | Deep venous thrombosis (HP:0002625) | 1.63959354 |
| 91 | Macroorchidism (HP:0000053) | 1.63167124 |
| 92 | Gangrene (HP:0100758) | 1.62248490 |
| 93 | Restrictive lung disease (HP:0002091) | 1.62087897 |
| 94 | Gastrointestinal dysmotility (HP:0002579) | 1.59840986 |
| 95 | Centrally nucleated skeletal muscle fibers (HP:0003687) | 1.59642782 |
| 96 | Nasal polyposis (HP:0100582) | 1.59376649 |
| 97 | Right ventricular cardiomyopathy (HP:0011663) | 1.59140935 |
| 98 | Ectropion (HP:0000656) | 1.58996798 |
| 99 | Abnormal blistering of the skin (HP:0008066) | 1.58922000 |
| 100 | Heterotopia (HP:0002282) | 1.58752404 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | TRIB3 | 4.63874474 |
| 2 | MAP4K1 | 3.59111685 |
| 3 | PRPF4B | 3.34719595 |
| 4 | RIPK4 | 2.49813139 |
| 5 | CDC42BPA | 2.37411570 |
| 6 | ERN1 | 2.24783434 |
| 7 | EEF2K | 2.21831680 |
| 8 | CDK12 | 2.20100887 |
| 9 | BLK | 2.19808726 |
| 10 | IRAK4 | 2.13398788 |
| 11 | SIK1 | 2.09486492 |
| 12 | CAMKK1 | 2.01984533 |
| 13 | EPHA2 | 1.94447034 |
| 14 | SMG1 | 1.91415236 |
| 15 | MAP3K13 | 1.75228893 |
| 16 | ICK | 1.74042286 |
| 17 | CAMK1D | 1.70512380 |
| 18 | CDK8 | 1.59699578 |
| 19 | PKN2 | 1.54096787 |
| 20 | ZAP70 | 1.53570291 |
| 21 | MAP2K3 | 1.45498833 |
| 22 | BTK | 1.42704366 |
| 23 | MAP3K7 | 1.40682954 |
| 24 | MELK | 1.39844271 |
| 25 | MST1R | 1.37915039 |
| 26 | MAP3K10 | 1.34914512 |
| 27 | TNK2 | 1.33636796 |
| 28 | ACVR1B | 1.29747411 |
| 29 | SIK2 | 1.28208524 |
| 30 | MAP3K14 | 1.27848810 |
| 31 | FGFR4 | 1.26351673 |
| 32 | TYK2 | 1.24851845 |
| 33 | IRAK3 | 1.23860324 |
| 34 | MAP3K3 | 1.20594251 |
| 35 | PRKD2 | 1.19180513 |
| 36 | MAPK11 | 1.16176403 |
| 37 | MARK2 | 1.13814770 |
| 38 | PTK6 | 1.11320095 |
| 39 | CAMKK2 | 1.09353019 |
| 40 | JAK3 | 1.08344308 |
| 41 | LIMK1 | 1.06185574 |
| 42 | GRK6 | 1.04242677 |
| 43 | HCK | 1.04179762 |
| 44 | NEK9 | 1.03323538 |
| 45 | EPHB1 | 1.03094425 |
| 46 | CSK | 1.02055015 |
| 47 | BRSK1 | 0.98692937 |
| 48 | CDK4 | 0.96401930 |
| 49 | SIK3 | 0.96374384 |
| 50 | ITK | 0.94230011 |
| 51 | MAP3K6 | 0.89346168 |
| 52 | TGFBR1 | 0.87955167 |
| 53 | CAMK1G | 0.87391667 |
| 54 | MAP3K11 | 0.87139750 |
| 55 | FGR | 0.87015895 |
| 56 | JAK1 | 0.86649800 |
| 57 | MAPK12 | 0.86098967 |
| 58 | DAPK2 | 0.84417365 |
| 59 | RIPK1 | 0.83924397 |
| 60 | TBK1 | 0.82363951 |
| 61 | MAP3K1 | 0.81216977 |
| 62 | SYK | 0.79562275 |
| 63 | TTN | 0.79420472 |
| 64 | PDPK1 | 0.79121890 |
| 65 | MTOR | 0.77564506 |
| 66 | MAPK15 | 0.77046967 |
| 67 | KSR2 | 0.73895612 |
| 68 | IKBKB | 0.66247578 |
| 69 | TAOK1 | 0.63796263 |
| 70 | WNK1 | 0.61621828 |
| 71 | MAP2K6 | 0.61357705 |
| 72 | CLK1 | 0.60711713 |
| 73 | TRPM7 | 0.59831666 |
| 74 | MAP3K2 | 0.58450596 |
| 75 | FES | 0.58159415 |
| 76 | CSF1R | 0.56476750 |
| 77 | TAOK2 | 0.56147189 |
| 78 | IRAK2 | 0.55991381 |
| 79 | FGFR3 | 0.55957472 |
| 80 | CAMK4 | 0.55914399 |
| 81 | PDK1 | 0.54599452 |
| 82 | MAPK7 | 0.54303594 |
| 83 | LYN | 0.53646373 |
| 84 | MAPKAPK2 | 0.51826961 |
| 85 | RPS6KC1 | 0.51797987 |
| 86 | RPS6KL1 | 0.51797987 |
| 87 | BRSK2 | 0.49523980 |
| 88 | IKBKE | 0.48509364 |
| 89 | BMPR2 | 0.48109882 |
| 90 | LCK | 0.47766744 |
| 91 | RPS6KA6 | 0.44912810 |
| 92 | MST4 | 0.44040497 |
| 93 | PDGFRB | 0.43120858 |
| 94 | STK10 | 0.42941712 |
| 95 | LRRK2 | 0.41973812 |
| 96 | PDGFRA | 0.41582244 |
| 97 | RET | 0.41556851 |
| 98 | CHUK | 0.39807079 |
| 99 | STK38 | 0.38900694 |
| 100 | BMX | 0.38658075 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 2.64663770 |
| 2 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 2.01045846 |
| 3 | Leishmaniasis_Homo sapiens_hsa05140 | 1.95352746 |
| 4 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.90628732 |
| 5 | Osteoclast differentiation_Homo sapiens_hsa04380 | 1.83606025 |
| 6 | Other glycan degradation_Homo sapiens_hsa00511 | 1.83335683 |
| 7 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 1.81744263 |
| 8 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 1.80391645 |
| 9 | VEGF signaling pathway_Homo sapiens_hsa04370 | 1.76089266 |
| 10 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 1.74959410 |
| 11 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 1.69709158 |
| 12 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 1.62473901 |
| 13 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.61733540 |
| 14 | Allograft rejection_Homo sapiens_hsa05330 | 1.58500854 |
| 15 | Tuberculosis_Homo sapiens_hsa05152 | 1.51767941 |
| 16 | Graft-versus-host disease_Homo sapiens_hsa05332 | 1.51235679 |
| 17 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 1.48022216 |
| 18 | Pancreatic cancer_Homo sapiens_hsa05212 | 1.47541829 |
| 19 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 1.47013674 |
| 20 | Influenza A_Homo sapiens_hsa05164 | 1.46917821 |
| 21 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.45975613 |
| 22 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.43450754 |
| 23 | Measles_Homo sapiens_hsa05162 | 1.41595860 |
| 24 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 1.38427100 |
| 25 | Bladder cancer_Homo sapiens_hsa05219 | 1.37373533 |
| 26 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.36543448 |
| 27 | Renal cell carcinoma_Homo sapiens_hsa05211 | 1.35087526 |
| 28 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 1.34444818 |
| 29 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 1.33240781 |
| 30 | Notch signaling pathway_Homo sapiens_hsa04330 | 1.33212824 |
| 31 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 1.32549783 |
| 32 | Primary immunodeficiency_Homo sapiens_hsa05340 | 1.30171131 |
| 33 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 1.23186095 |
| 34 | Viral myocarditis_Homo sapiens_hsa05416 | 1.22752067 |
| 35 | mTOR signaling pathway_Homo sapiens_hsa04150 | 1.22286165 |
| 36 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 1.18775835 |
| 37 | Hepatitis B_Homo sapiens_hsa05161 | 1.18731428 |
| 38 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 1.16530759 |
| 39 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.15408772 |
| 40 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.14341979 |
| 41 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 1.08165831 |
| 42 | Asthma_Homo sapiens_hsa05310 | 1.07136167 |
| 43 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 1.06404566 |
| 44 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.06329714 |
| 45 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 1.05497505 |
| 46 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.04492527 |
| 47 | Antigen processing and presentation_Homo sapiens_hsa04612 | 1.04165332 |
| 48 | Apoptosis_Homo sapiens_hsa04210 | 1.03996172 |
| 49 | Endometrial cancer_Homo sapiens_hsa05213 | 1.02385269 |
| 50 | Platelet activation_Homo sapiens_hsa04611 | 1.02308378 |
| 51 | Colorectal cancer_Homo sapiens_hsa05210 | 0.99849365 |
| 52 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.99502206 |
| 53 | Hepatitis C_Homo sapiens_hsa05160 | 0.99450344 |
| 54 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.92761443 |
| 55 | Insulin resistance_Homo sapiens_hsa04931 | 0.92685201 |
| 56 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.89209513 |
| 57 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.88329456 |
| 58 | HTLV-I infection_Homo sapiens_hsa05166 | 0.86314891 |
| 59 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.86083062 |
| 60 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.85405187 |
| 61 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.84176592 |
| 62 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.82212703 |
| 63 | Prostate cancer_Homo sapiens_hsa05215 | 0.82180476 |
| 64 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.80877570 |
| 65 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.80706671 |
| 66 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.79421283 |
| 67 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 0.78635773 |
| 68 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.78506646 |
| 69 | Malaria_Homo sapiens_hsa05144 | 0.78490906 |
| 70 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.78290208 |
| 71 | MicroRNAs in cancer_Homo sapiens_hsa05206 | 0.77965625 |
| 72 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.76498222 |
| 73 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.76413161 |
| 74 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.76016316 |
| 75 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.75271402 |
| 76 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.75133668 |
| 77 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.74490298 |
| 78 | Legionellosis_Homo sapiens_hsa05134 | 0.73258345 |
| 79 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.72887994 |
| 80 | Glioma_Homo sapiens_hsa05214 | 0.71558004 |
| 81 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.71108044 |
| 82 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.69648198 |
| 83 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.67112202 |
| 84 | Amoebiasis_Homo sapiens_hsa05146 | 0.66840857 |
| 85 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.66512479 |
| 86 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.65088756 |
| 87 | Shigellosis_Homo sapiens_hsa05131 | 0.65051038 |
| 88 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.64940689 |
| 89 | Endocytosis_Homo sapiens_hsa04144 | 0.63421713 |
| 90 | Lysosome_Homo sapiens_hsa04142 | 0.62888262 |
| 91 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.62079171 |
| 92 | Pertussis_Homo sapiens_hsa05133 | 0.60514179 |
| 93 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.59269915 |
| 94 | Focal adhesion_Homo sapiens_hsa04510 | 0.57463069 |
| 95 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.54128832 |
| 96 | ABC transporters_Homo sapiens_hsa02010 | 0.53204455 |
| 97 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.53067551 |
| 98 | Lysine degradation_Homo sapiens_hsa00310 | 0.51312330 |
| 99 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.50234754 |
| 100 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.47168040 |

